Search

Cervical cancer (CC) is the fourth leading cause of death in women worldwide and despite the introduction of screening programs about 30% of patients presents advanced disease at diagnosis and 30-50% of them relapse in the first 5-years after treatment. According to FIGO staging system 2018, stage IB3-IVA are classified as locally advanced cervical cancer (LACC); its correct therapeutic choice remains still controversial and includes neoadjuvant chemoradiotherapy, external beam radiotherapy, brachytherapy, hysterectomy or a combination of these modalities. In this review we focus on the most appropriated therapeutic options for LACC and imaging protocols used for its correct follow-up. We explore the imaging findings after radiotherapy and surgery and discuss the role of imaging in evaluating the response rate to treatment, selecting patients for salvage surgery and evaluating recurrence of disease. We also introduce and evaluate the advances of the emerging imaging techniques mainly represented by spectroscopy, PET-MRI, and radiomics which have improved diagnostic accuracy and are approaching to future direction. [ABSTRACT FROM AUTHOR]

A new approach for obtaining metasurfaces realized by using frequency selective surfaces with reduced periodicity printed on a new class of high dielectric constant materials is presented. The proposed engineered ad-hoc materials and the innovative electromagnetic design provide an improvement of the overall device in terms of compactness and angular stability, as shown by the use of our novel band vs. incidence angles chart. © 2009 Wiley Periodicals, Inc. Microwave Opt Technol Lett 51: 2753–2758, 2009; Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/mop.24731 [ABSTRACT FROM AUTHOR]